Grifols (GIFLF) Return on Invested Capital (2011 - 2020)
Grifols (GIFLF) reported Return on Invested Capital of 0.01% for Q1 2020, little changed on a YoY basis from 0.01% in Q2 2019, and up 16.63% quarter-over-quarter from 0.01% in Q4 2019.
Grifols (GIFLF) Return on Invested Capital (2011 - 2020) Analysis & Trends
Grifols has reported Return on Invested Capital for 8 years, with the latest figure at 0.01% in Q1 2020.
- For the quarter ending Q1 2020, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2020 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital for Q1 2020 stood at 0.01%, up from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q2 2018, with the low at 0.0% in Q2 2017.
- Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2016.
- Annual changes were most pronounced in 2017 — Return on Invested Capital slipped 1 bps — and 2018, when it gained 2 bps.
- Grifols' Return on Invested Capital stood at 0.0% in 2016, then soared by 764 bps to 0.0% in 2017, then jumped by 314 bps to 0.01% in 2018, then slipped by 14 bps to 0.01% in 2019, then grew by 17 bps to 0.01% in 2020.
- The last three Return on Invested Capital figures came in at 0.01% (Q1 2020), 0.01% (Q4 2019), and 0.01% (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | 0.00% |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.01% |
| Dec 31, 2019 | 0.01% |
| Mar 31, 2019 | 0.01% |
| Dec 31, 2018 | 0.01% |
| Jun 30, 2018 | 0.02% |
| Mar 31, 2018 | 0.01% |
| Dec 31, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.01% |
| Dec 31, 2015 | 0.00% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2012 | 0.01% |
| Sep 30, 2012 | 0.01% |
| Jun 30, 2012 | 0.01% |
| Mar 31, 2012 | 0.01% |
| Dec 31, 2011 | 0.01% |
| Sep 30, 2011 | 0.01% |